Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems Inc.

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Inspire Medical Systems, with a price target of $50....

Current Quarter	$-0.22	Next Quarter	$0.3
Current Year	$0.91	Next Year	$1.47
QoQ Growth	+236.4%	YoY Growth	+61.5%
3Y EPS CAGR	+72.1%	Target Price	$55.50
Consensus	Buy	Upside	+28.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INSP	$43.07	+2.01%	922.06K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INSP	$43.07	+2.0%	922.06K
3
4
5
6

INSP

INSP

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Inspire Medical Systems Inc. Data in Excel

Get Inspire Medical Systems Inc. Data in Excel